9,10-dimethyl-1,2-benzanthracene has been researched along with cortistatin 14 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Álvarez-Benito, M; Castaño, JP; de Lecea, L; Gahete, MD; L-López, F; López-Miranda, J; Luque, RM; Ortega-Salas, R; Pozo-Salas, AI; Sánchez-Sánchez, R; Villa-Osaba, A | 1 |
1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and cortistatin 14
Article | Year |
---|---|
Lack of cortistatin or somatostatin differentially influences DMBA-induced mammary gland tumorigenesis in mice in an obesity-dependent mode.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogenesis; Female; Humans; Mammary Glands, Animal; Mammary Neoplasms, Animal; Mice; Mice, Knockout; Mice, Obese; Neuropeptides; Somatostatin | 2016 |